Department of Physiology, College of Korean Medicine, Kyung Hee University, Number 1 Hoegi-dong, Dongdaemungu, Seoul 130-701, Republic of Korea.
Division of Allergy and Respiratory System, College of Korean Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea.
Evid Based Complement Alternat Med. 2014;2014:958965. doi: 10.1155/2014/958965. Epub 2014 Mar 3.
Maekmoondong-tang (MMDT) has long been used in Asian countries to treat respiratory diseases. However, the precise mechanisms underlying its effects on asthma are unknown. This study was conducted to evaluate the protective effects of MMDT in a cockroach allergen (CKA-)induced animal model of allergic asthma. After being challenged with CKA, the number of macrophages, eosinophils, neutrophils, lymphocytes, and total cells in the bronchoalveolar lavage fluid (BALF) was evaluated. The Th2 specific cytokines IL-4, IL-5, and IL-13 were also analyzed in BALF along with IgE levels in serum. For histological analysis, hematoxylin and eosin (H&E) staining, periodic acid-Schiff (PAS) staining, and immunohistochemical staining were performed. In addition, airway hyperresponsiveness was assessed by noninvasive plethysmography. The cellular profiles and histopathologic analysis demonstrated that peribronchial and perivascular inflammatory cell infiltrates were significantly decreased in the MMDT-treated groups compared with the cockroach extract-injected (CKA) groups. In addition, the IgE, IL-4, IL-5, and IL-13 levels were significantly decreased in the MMDT group. MMDT treatment also significantly attenuated airway hyperresponsiveness. These results demonstrated that MMDT significantly reduced the hallmark signs of asthma: elevated serum IgE, airway eosinophilia, airway remodeling, mucus hypersecretion, and airway hyperresponsiveness. The remarkable antiasthmatic effects of MMDT suggest its therapeutic potential in allergic asthma treatment.
美克莫顿汤(MMDT)长期以来一直被亚洲国家用于治疗呼吸系统疾病。然而,其对哮喘影响的确切机制尚不清楚。本研究旨在评估 MMDT 在蟑螂过敏原(CKA)诱导的变应性哮喘动物模型中的保护作用。用 CKA 攻毒后,评估支气管肺泡灌洗液(BALF)中巨噬细胞、嗜酸性粒细胞、中性粒细胞、淋巴细胞和总细胞的数量。还分析了 BALF 中的 Th2 特异性细胞因子 IL-4、IL-5 和 IL-13 以及血清中的 IgE 水平。进行组织学分析时,进行了苏木精和伊红(H&E)染色、过碘酸-希夫(PAS)染色和免疫组织化学染色。此外,通过非侵入性体积描记术评估气道高反应性。细胞特征和组织病理学分析表明,与蟑螂提取物注射(CKA)组相比,MMDT 治疗组的支气管和血管周围炎症细胞浸润明显减少。此外,MMDT 组的 IgE、IL-4、IL-5 和 IL-13 水平显著降低。MMDT 治疗还显著减轻了气道高反应性。这些结果表明,MMDT 显著减轻了哮喘的标志性特征:血清 IgE 升高、气道嗜酸性粒细胞增多、气道重塑、粘液分泌过多和气道高反应性。MMDT 的显著抗哮喘作用表明其在过敏性哮喘治疗中的治疗潜力。